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a  b  s  t  r  a  c  t
Objective:  To  analyze  the  causes  of retracted  publications  and  the  main  characteristics  of their  authors.
Method:  A  descriptive  cross-sectional  study  was  designed  including  all  retracted  publications  from  Jan-
uary 1st,  2013-December  31st,  2016  indexed  in  PubMed.  The  causes  of  retraction  were  classified  as:  data
management,  authorship  issues,  plagiarism,  unethical  research,  journal  issues,  review  process,  conflict  of
interest,  other  causes,  and  unknown  reasons.  Then,  misbehaviour  was  classified  as  misconduct,  suspicion
of misconduct  or no  misconduct  suspicion.
Results:  1,082  retracted  publications  were  identified.  The  retraction  rate  for the  period  was  2.5  per  10,000
publications.  The  main  cause  of  retraction  was misconduct  (65.3%),  and  the  leading  reasons  were  pla-
giarism,  data  management  and compromise  of  the review  process.  The  highest  proportion  of  retracted
publications  corresponded  to Iran  (15.52  per 10,000),  followed  by Egypt  and  China  (11.75  and  8.26  per
10,000).
Conclusions:  Currently,  misconduct  is the  main  cause  of retraction.  Specific  strategies  to limit  this  phe-
nomenon  must  be implemented.  It would  be useful  to standardize  reasons  and  procedures  for  retraction.
The  development  of  a  standard  retraction  form  to be permanently  indexed  in a database  might  be relevant.
© 2018  SESPAS.  Published  by  Elsevier  España,  S.L.U.  This  is an  open  access  article  under  the  CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Mala  conducta  como  principal  causa  para  la  retractación.







r  e  s  u  m  e  n
Objetivo:  Analizar  las causas  de las  retractaciones  y  las  características  fundamentales  de  sus  autores.
Método:  Se  diseñó  un  estudio  descriptivo,  transversal,  que  incluyó  todas  las  publicaciones  con
retractación  entre  el 1 de enero  de  2013  y  el  31  de  diciembre  de  2016  indexadas  en PubMed.  Las  causas
de  la  retractación  fueron  clasificadas  como  manejo  de datos,  asuntos  de  autoría,  plagio,  investigación  no
ética, asuntos  de  las  revistas,  proceso  de  revisión,  conflictos  de  intereses,  otras  causas  y  razones  descono-
cidas. Tras  esto,  la conducta  indebida  fue  clasificada  como  mala  conducta,  sospecha  de  mala  conducta  y
sin sospecha  de  mala  conducta.
Resultados:  Se  identificaron  1.082  publicaciones  retractadas.  La proporción  de  publicaciones  retractadas
fue  de  2,5  por  cada  10.000  publicaciones  para  el  periodo  evaluado.  La principal  causa  de  retractación  fue
la mala  conducta  (65,3%),  y las  causas  principales  fueron  plagio,  manejo  de  los  datos  y  compromiso  del
proceso  de revisión.  La mayor  proporción  de publicaciones  retractadas  correspondió  a  Irán  (15,52  por
10.000),  seguido  de  Egipto  y China  (11,75  y 8,26 por  10.000,  respectivamente).
Conclusiones:  Actualmente,  la mala  conducta  es  la  principal  causa  de  retractación.  Deberían  imple-
mentarse  estrategias  específicas  para  limitar  este  fenómeno.  Sería  de  utilidad  uniformar  los  motivos
y  procedimientos  para  la  retractación.  Podría  ser  apropiado  el  desarrollo  de  un  formulario  estándar  de
retractación  que  sea  indexado  permanentemente  en  una  base  de  datos.
© 2018  SESPAS.  Publicado  por  Elsevier  España,  S.L.U.  Este  es un  artı́culo  Open  Access  bajo  la  licencia∗ Corresponding author.
E-mail address: alberto.ruano@usc.es (A. Ruano-Raviña).
https://doi.org/10.1016/j.gaceta.2018.01.009
213-9111/© 2018 SESPAS. Published by Elsevier España, S.L.U. This is an open access ar
d/4.0/).CC BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
IntroductionThe number of retracted papers in last years is growing.1 This
phenomenon is probably linked to the increase in the number of
published papers and scientific journals, but also to the improve-
ment in methodologies to detect fraud or misconduct, such as





















































conference abstract publications (Fig. 1). So, the total number of
retracted publications for the study period was  1,082, while the
number or published papers for the same period was  4,384,945. The
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oftware to detect plagiarism, mandatory registry of clinical trials,
equired declaration of conflict of interest and so on.2
The reasons for retracting a publication are diverse, changing
rom an unintentional editorial mistake to an intentional fraud (i.e.
ata or image manipulation, fabricated conclusions or duplication
f publications).3,4 Hence, two independent retraction categories
ight be differentiated; a first one based on mistakes and the
econd based on intentional misconduct.5,6 Whatever the rea-
on, retraction represents a threat to the integrity of the scientific
rogress, by breaking the confidence on scientific community, lead-
ng to wrong or uncertain decisions and because of the risk of
onducting future studies based on inaccurate conclusions. Loss of
esearchers’ credibility is also attributable to misconduct. Further-
ore, duplicated publications would interfere on meta-analytic
echnics, usually leading to an overestimation of the studied effect
nd inflated CVs of those using this practice.7,8
The issue of misconduct and its characteristics has been focused
nder diverse approaches, and different frequencies for the main
auses of retractions have been observed.1,5 New categories of mis-
onduct have also been reported recently.9 There is a need for
 better understanding and sorting of the multiple and current
auses of retraction before attempting to set up editorial measures.
lso, misconduct characteristics from authors in emerging coun-
ries need to be elucidated, and an updated, homogeneous and
igorous classification of the retraction papers is needed.10
A deeper knowledge on the causes of retraction is therefore crit-
cal to raise awareness of Editors and readers of scientific journals
s a first step before establishing measures to limit this phe-
omenon. Thus, we aimed to describe retracted publications and
heir main characteristics (including some related to authors) in
ournals indexed in PubMed.
ethods
A descriptive cross-sectional study was conducted through a
ubMed search from January 1st, 2013 to December 31st, 2016
earching for articles indexed as “retracted publication”. The last
ccess to the database was April 30th, 2017.
earch strategy
The search strategy was the following (“retracted publica-
ion”[Publication Type] OR “retracted publication”[All Fields]) AND
“2013/01/01”[PDAT]: “2016/12/31”[PDAT]). Conference abstract
ublications were not included because the nature of the publi-
ation was completely different from the reported and included
apers. Access to abstract or full article was not required to be
ncluded.
ata extraction
The following information was obtained for each paper classi-
ed as retracted: total number of authors, institutions (classified
s university, health care facility, research center, industry, and
ther), publication type (classified as original report, review, case
eport, case series, letter, or editorial), subject of study (catalogued
s human, animal, basic or other), country of origin of first author
nd original language.
efinition of cause of retraction
Retracted publications were classified based on retraction notice
arrative and on the categories proposed by the Committee of
ublishing Ethics (COPE) definitions and previous classifications.3,4
ine main categories were finally considered which are classified
s follows:ac Sanit. 2019;33(4):356–360 357
1) Data. Based on data management by authors. On the grounds
that the findings are unreliable, either as a result of an honest
error (scientific error, mistake on data processing or analysis) or
as the result of an intentional manipulation, creation or fabrica-
tion of data or images.
2) Authors. Including authorship dispute, non-informed authors
involved, and fictitious authors.
3) Plagiarism. Including self-plagiarism, redundant or duplicated
publications. It also includes the use of material previously pub-
lished by others without appropriate quoting or permission.
4) Unethical research. Comprising no ethical approval, or lack of
proper informed consent.
5) Journal issues. Covering editorial duplication of contents or
uploading an incorrect manuscript or version.
6) Review process. Fake peer review reports or other issues related
with the peer-review process.
7) Conflict of interest. Undisclosed conflict of interest.
8) Other. Including request by authors or editors for retraction if
not described further.
9) Unknown.
Among these categories, misbehavior was  classified further as
misconduct (fraud, as an opposite of honest error), suspicion of
misconduct and no misconduct suspicion.
Data collection and classification was  performed by ICV, and
doubtful assignments were discussed with ARR.
Data analysis
The percentage of total retracted publications or retracted pub-
lications because of misconduct per 10,000 PubMed publications
was calculated, dividing the total number of retracted publications
or the number or retracted publications because of misconduct by
the total number of publications in PubMed for the study period.
Cumulative incidence rates were expressed as percentages. The
same approach was  used to calculate the proportion of retracted
publications by author’s country of origin; the denominator was
calculated identifying publications per country and year using
the field description [Affiliation]. STATA/SE® v13 (College Station,
Texas) was used for all statistical analyses.
Results
The number of records identified through the database search-
ing was 1,091; nine of them were excluded as they belonged toanalysis
(n = 1,082)
Figure 1. Flow chart.
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Table 1
Characteristics of retracted publications (2013-2016; n = 1,082).









Case report 51 (4.7)
Letter 14 (1.3)









Institution of first author
University 816 (75.4)
Health care facility 127 (11.7)














































Reasons for retraction and proportion of misconduct by category.
Reason of retraction Articles, n (%) Misconduct, n (%)
Plagiarism 354 (32.7) Yes 354 (100)
No 0
Uncertain 0
Data 352 (32.5) Yes 129 (36.6)
No 1 (0.3)
Uncertain 222 (63.1)
Review process compromised 152 (14.1) Yes 152 (100)
No 0
Uncertain 0
Authors 64 (5.9) Yes 42 (65.6)
No 0
Uncertain 22 (34.4)
Journal 47 (4.3) Yes 0
No 44 (93.6)
Uncertain 3 (6.4)
Ethical 23 (2.1) Yes 19 (82.6)
No 1 (4.4)
Uncertain 3 (13.0)
Conflicts of interest 7 (0.7) Yes 7 (100)
No 0
Uncertain 0
Other 54 (5.0) Yes 4 (7.4)
No 8 (14.8)
Uncertain 42 (77.8)
Unknown 29 (2.7) Yes 0
No 0Number of authors
Figure 2. Misconduct distribution by number of authors.
The main characteristics of retracted publications are described
n Table 1. Retracted papers were mainly written by two  to four
uthors (38.7%). Single author was only present in 5% of retractions.
he distribution of misconduct by number of authors is described
n Figure 2. Regarding the type of article, 840 (77.6%) were original
apers, and 150 (13.9%) reviews, followed by 51 (4.7%) case reports.
mong these retracted papers, the most frequent subjects of study
ere human and basic science with 435 (40.2%) and 406 (37.5%)
etractions, respectively. Considering first author institution, the
ost frequent origin of papers was university, representing a 75.4%
f retractions. Main language of retracted publications was  English,
nd only eight papers were published in other languages
Reasons for retraction are shown in Table 2. Plagiarism and
ata processing related issues were the most common rea-
ons for retraction of publications, with 354 (32.7%) and 352
32.5%) manuscripts retracted, respectively. Significant differences
ppeared when analyzing the proportion of misconduct within cat-
gories, as misconduct represented a 100% in the case of plagiarism,
nd only a 36.6% were certainly retracted because of misconduct in
he case of data process. Review process compromised representedUncertain 29 (100)
the third group in order of frequency, comprising a 14% of the
total of retracted publications, again with a 100% accounting for
misconduct. Authors’ issues represented a 5.9% of the retracted
papers.
Of the 1,082 retracted publications, a total of 707 were classified
as misconduct, representing a 65.3% of the total number of retrac-
tions, with a rate of 1.6 per 10,000 published papers. Misconduct
proportion among retracted papers was 67.1%, 52.2%, 67.2% and
70% for 2013, 2014, 2015 and 2016, respectively.
Regarding country of origin, two countries had frequencies
greater than 10 retracted papers by 10,000 published papers (1
per 1,000 published papers). The highest frequency of retracted
publications corresponded to Iran, with 15.52 papers retracted per
10,000 papers published (Table 3). Egypt retracted 11.75 of every
10,000 papers published. China followed the list with a rate of
retractions of 8.26. Peer review fraud was only related to six coun-
tries (Table 4) and was  most frequent in China followed by Iran.
Discussion
We  have found that 2.5 per 10,000 published papers were
retracted during the period 2013-2016. Of them, confirmed mis-
conduct accounts for 65.3% of retracted publications. This study
supports the idea that in late years the causes of retraction are mov-
ing from unintentional error to misconduct.1 These results have
been achieved through a research including all causes of retraction,
and not limited to a specific aspect.10–12 Furthermore, we have to
consider that the intentional misconduct we have observed only
underrepresents the real rate of intentional misconduct.13,14 It is
not currently possible to assess the real rate of published research
reflecting misconduct and this paper only shows those misconduct
types that are detected more easily by scientific journals. Other
questionable research practices are beyond the scope of the present
research. Specific studies using anonymized surveys have observed
that conducts such as the change of study design, methodology or
results in response to pressure from a funding source, or even the
fail to present data contradicting one’s own  previous research are
I. Campos-Varela, A. Ruano-Raviña / G
Table  3
Proportion of retractions per country of origin (2013-2016).
Country Total publications Retractions Proportion/10,000
Iran 55,407 86 15.52
Egypt 9,358 11 11.75
China 481,888 398 8.26
India 143,884 96 6.67
Malaysia 17,072 6 3.51
Turkey 64,951 21 3.23
Thailand 16,521 5 3.03
Saudi Arabia 20,678 6 2.90
Korea 124,763 33 2.65
Italy 168,109 33 1.96
Singapore 25,477 5 1.96
U.S.A. 816,464 157 1·92
Sweden 63,369 10 1.58
Taiwan 51,895 8 1.54
Spain 112,588 13 1.15
Japan 200,623 23 1.15
Denmark 46,865 5 1.07
Brazil 88,915 9 1.01
Switzerland 69,433 7 1.01
Canada 156,555 14 0.89
U.K. 240,414 21 0.87
Australia 142,701 11 0.77
France 157,316 12 0.76
Germany 222,501 16 0.72
Netherlands 105,487 6 0.57
Table 4



































isconduct practices that are relatively frequent, but impossible to
sses under this focus.13,14
Retraction due to misconduct is probably the effect of an increas-
ng pressure on authors to publish.15,16 This demand is patent in
he case of peer review fraud, with authors directly providing fake
eviewers to journal editors.9 Up to 14% of retractions might have
een avoided with a more severe control over the review pro-
ess, and not entrusting authors with the responsibility to provide
eviewers and non-accredited email addresses. Editorial process
as to be aware of this and other potentially new ways of defraud-
ng, and learn, innovate and improve peer-review quality process
ver time.17 Meaningful proposals have been made to fight this
ising pressure, in the line that scientific merits should not be eval-
ated in order of quantity, but of quality, it might be more valuable
o ask a researcher to select his or her three most significant publi-
ations when evaluation needed, instead of asking to list as many
ublications as possible.18
Errors are less common than described years ago, and are
ssentially related to editorial or journal mistakes, such as papers
ublished twice.5 These errors, despite undesirables, can be solved
hrough increasing editorial process quality, and once identified do
ot cause damage to the scientific process.
It is of particular interest the fact that most authors causing mis-
onduct come from a quite limited group of countries such as Iran,
ollowed by Egypt and China. We  do not have a definitive explana-
ion for this finding, however there are some data suggesting that
pecific pressures for publishing in those countries might play a
ole.15 A possible explanation might also be less stringent control
olicies on the researchers’ publication track or a higher aware-
ess of Editors due to other experiences with research comingac Sanit. 2019;33(4):356–360 359
from these countries in the past.19 A relationship between first
authors affiliated with lower-income countries and publications
retracted for plagiarism has been previously described.10 Other
factor to be taken into account is the language, as there is also a
higher rate of plagiarism when first authors do not have English
as first language,10 suggesting a difficulty to use original wording.
Our results about location of peer review fraud are consistent with a
previous description,9 and highlights the association between pres-
sure to publish and the development of new ways to achieve the
demanded aim.
Regarding number of authors, in previous studies, single-author
represented a 6.6% of the retracted publications,20 this figure is con-
sistent with our results, suggesting that probably a single person
has less tendency to commit misconduct, and probably there is less
group pressure to meet targets. Otherwise, the highest proportion
of errors among single author papers, suggests that errors might be
higher when the control of errors falls to one person.
Original articles are the most retracted, probably related to the
high number of this publication type or perhaps because it is the
publication type which has more quality thresholds. This is usually
the publication type where a peer-review policy is strictly enforced.
However, a reliable analysis of the total number of original articles
published through the study period was  not feasible, as PubMed
filters are not rigorous on classifying nature of papers.10
We have not been able to describe misconduct by gender
because the author’s name is frequently only specified by the
family name and initial, this fact makes confusion likely to hap-
pen with authors from different cultures or countries. This is not
possible even considering institutions to identify them, because
authors can move or have more than one affiliation. Likely, co-
authorship does not guarantee a comprehensive identification of
authors. Others have attempted this description before, reporting
that it was not exceptional for an author to have more than one
paper retracted.20,21 Nevertheless, predominance for male gender
has been reported, among 228 researchers identified, 65% were
male, representing a 88% for faculty members.22 It might be possi-
ble to evaluate individual authors by reviewing the annual reports
of the U.S. Office of Research Integrity (ORI).22,23 This is an exhaus-
tive and detailed approach, but limited in terms of extent, as few of
the papers identified in PubMed are detailed by ORI. This lack of reli-
ability in identification of authors would be solved if, as desirable,
ORCID identifiers became generalized. Other potential solution
would be Medline including a description of the first author gender.
This would facilitate not only misconduct analysis, but also other
analyses related to publishing policies related to gender.
One restraint found was  the limited access to some of the
retracted papers, limiting the ability to track authors, institutions
or funding.24 We  firmly believe that retracted publications should
not be removed, instead, they should be marked and clearly identi-
fied as retracted, but available to access. Remove traces only helps
misconduct researchers to hide and difficult research in this field.
Similarly, some retraction notes are clear and descriptive of the
cause of retraction, but others do not provide information at all,
or this is minimum, and do not allow to understand the cause
of retraction.3 Also, despite PubMed is the main biomedical bib-
liographic database, is not the only one. Therefore, the external
validity of the results might be limited. There are other limitations
derived from the nature of the data, first that an exact search can-
not be reproduced since PubMed retrospectively includes records,
so there is an increment on the number of papers retracted, as can
be checked in Medline using the corresponding MeSH term, and
second, derived from the former, this fact precludes the calculation
of incidence per year, as it was  not calculated initially.This PubMed based analysis provides the possibility, despite
the lack of certain details, to evaluate the largest possible series
of cases and to have a realistic and general view of the retraction
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rocess, and specifically the author’s pattern involved in retraction
n recent years. A further strength of this study is the classification
sed, based on identifying first the cause of retraction, followed
y assigning the misconduct pattern. Additionally, Medline guar-
ntees a good coverage of medical journals, as those not indexed
ave less possibilities to have retractions, as in general terms, they
ave less strict review procedures, editorial committees less pro-
essionals or with less scientific prestige.
We cannot study deeply misconduct causes or types using exclu-
ively a PubMed search as we have done. We  should highlight
hat any type of misconduct found by us, and overall percent-
ge of misconduct is underestimated, and we do not know the
eal misconduct rate among published research.1,13,14 We  can-
ot analyze typical causes of misconduct such as guest or ghost
uthorship, non-declaration of conflict of interests, selection of
on-independent referees (friends, colleagues) and other miscon-
uct causes, which would require an in-depth analysis. A different
ethodology based on surveys might help to approach scientific
onduct, going beyond the identifiable misconduct of studies such
s this one, but with rate of response and sincerity as the main
imitation, specially from those misbehaving scientists.13,14
We  also have to acknowledge a limited capacity to classify publi-
ations as misconduct or not, if not clearly detailed in the retraction
ote. This has formerly been a source or errors, as publications
lassified initially as honest errors,1 were later reclassified as mis-
onduct or possible misconduct.25
In summary, retraction of scientific publications is a phe-
omenon mainly related to misconduct. Strategies to limit
etraction of publications have to be displayed and directed to the
ifferent causes of retraction. Given the described geographic pat-
erns, special awareness on manuscript from particular countries
ight be considered. It would be useful to standardize reasons and
rocedures for retraction, and we propose the development of a
tandard retraction form whose results should be indexed perma-
ently in databases such as Medline.
What is known about the topic?
The number or retracted publications is increasing. Rea-
sons for retractions, retraction frequency by countries and
characteristics of authors involved are not well known.
What does this study add to the literature?
This paper provides a comprehensive analysis of retracted
publications in medical journals and their authors. The current
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